-Frontine The finalised chapter on health in the 12th Plan document envisages a large role for the private sector in health care. A chapter on health prepared for the draft 12th Five Year Plan Document in July received a lot of criticism for its limited understanding of universal health care and its diluted commitment to increase public expenditure on health. If the revised version is any indication, there has not been...

-The Hindu The Rashtriya Swasthya Bima Yojana (RSBY) — a health insurance scheme that provides free hospitalisation to the poor — would become a major fiasco if insurance companies continue to throw a spanner, reveals a study. The Rashtriya Swasthya Bima Yojana (RSBY) — a health insurance scheme that provides free hospitalisation to the poor — would become a major fiasco if insurance companies continue to throw a spanner, reveals a World...

-Agence-France Presse Rural Development Minister Jairam Ramesh has said that the country's public health system had "collapsed" in a blunt assessment of his government's failure to extend a social safety net for the poor. Mr Ramesh, known as a maverick with often outspoken views, stressed that 70 per cent of spending on health was out of people's own pockets, making it the single most important reason for indebtedness in rural areas. "We all...

-The Hindu Health sector outlay tripled to Rs.3-lakh crore Prime Minister Manmohan Singh said on Saturday that the allocation for the health sector during the 12th Plan had been increased three times over the previous Plan allotment to address complex challenges. The outlay in the 12th Plan had been fixed at Rs. 3-lakh crore, which was 1.95 per cent of the Gross Domestic Product. During the last Plan period, the sector had got...

-The Times of India Medicines in India may not be sold under brand names in the near future. In its biggest move to push generic drugs and do away with brand names, the Union health ministry has ordered states to stop issuing licence for the manufacture or sale of drugs on the basis of their brand name. All pharmaceutical firms applying for licence to market or manufacture fixed dose combination (FDC) drugs will...